Comparisons
Lab guides, compound files and side-by-side comparisons. Written for researchers, with sources.
Comparisons
8 shownComparisonsComparisonsTirzepatide vs Semaglutide: Two Receptor Strategies, ComparedCompare dual and single receptor agonism, what direct trials measured, and why clinical findings do not establish equivalence for research vials.5 min readComparisonsComparisonsRetatrutide vs Semaglutide: Triple Agonism and the EvidenceSeparate receptor biology, published obesity trials, and new company-reported diabetes results in this comparison of retatrutide and semaglutide research.5 min readComparisonsComparisonsBPC-157 vs TB-500: What the Research Actually ComparesCompare BPC-157 with the TB-500 fragment while separating cell and animal findings from full-length thymosin beta-4 studies and unsupported human claims.5 min readComparisonsComparisonsCJC-1295 DAC vs No DAC: Why the Modification MattersLearn why CJC-1295 research must distinguish the albumin-binding DAC construct from no-DAC material before interpreting half-life and growth-hormone findings.5 min readComparisonsComparisonsIpamorelin vs GHRP-2 vs GHRP-6: Selectivity in ContextExamine where ipamorelin selectivity claims came from, how GHRP-2 appetite research adds context, and why model-specific results need careful interpretation.5 min readComparisonsComparisonsBacteriostatic vs Sterile Water: What Changes in the LabUnderstand the preservative difference, why solvent labels matter, and what neither water type can tell you about a research peptide’s stability.5 min readComparisonsComparisonsSingle, Dual, and Triple Agonists: What Receptor Count MeansCompare single, dual, and triple receptor strategies, why multi-agonists are single engineered molecules, and what receptor count can and cannot explain.5 min readComparisonsComparisonsRetatrutide vs Tirzepatide: Triple vs Dual Agonist ComparedTwo receptors or three? How retatrutide and tirzepatide differ, what the trials show, and what is still unknown.3 min read